-
February 18, 2015 Lupin PR – Lupin Launches InspiraChamber Anti-Static Valved Holding Chamber_ Expands US Brands Portfolio
-
February 17, 2015 Lupin and Celon Announce Strategic Development and Licensing Agreement for Generic Advair Diskusi®
-
February 3, 2015 Strong Margins, Robust Profits Quarter III Results, FY 2014-15 Net Sales up 5%, EBITDA up 20%, Net Profit up 26%
-
February 2, 2015 Lupin Receives FDA Approval for Generic Vancocin® Capsules
-
January 6, 2015 Lupin launches Generic DIOVAN® Tablets
-
December 30, 2014 Lupin Receives Tentative Approval for Generic Prezista® Tablets
-
December 26, 2014 Lupin Receives FDA Approval for Generic Epivir® Tablets
-
December 11, 2014 Lupin Launches Authorized Generic for Celebrex® Capsules
-
November 3, 2014 Lupin Receives FDA Approval for Generic Celebrex® Capsules
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications